Parameters | Value | Parameters | Value | ||
---|---|---|---|---|---|
Physicochemical property | Molecular weight | 498.23 | Distribution | VD | 0.551 |
Volume | 520.78 | BBB penetration | + | ||
Density | 0.957 | Metabolism | CYP1A2 inhibitor | – | |
nHA | 8 | CYP1A2 substrate | + | ||
nHD | 1 | CYP2C9 inhibitor | + | ||
nRot | 13 | CYP2C9 substrate | + | ||
nRing | 4 | CYP2D6 inhibitor | + | ||
MaxRing | 9 | CYP2D6 substrate | + | ||
nHet | 8 | Excretion | CL | 5.826 | |
fChar | 0 | T1/2 | 0.659 | ||
TPSA | 91.31 | Toxicity | AMES toxicity | – | |
logP | 4.094 | H-HT | – | ||
logD | 3.377 | AMES toxicity | – | ||
Absorption | Caco-2 permeability | − 5.135 | Carcinogencity | – | |
MDCK permeability | 3.2e−05 | Skin sensitization | – | ||
Pgp-inhibitor | – | Acute toxicity rule | 0 | ||
Pgp-substrate | – | Medicinal chemistry | SAscore | 2.325 | |
HLA | + | Lipinski rule | Accepted |